8-KLeadership ChangesRegulation FDOther Events+1

CARDINAL HEALTH INC 8-K Report, Executive Changes (Nov 13, 2006)

Filed November 13, 2006For Securities:CAH

Summary

This 8-K filing from Cardinal Health, Inc. (CAH) on November 13, 2006, primarily details significant executive and board-level changes. Key among these is the appointment of Mark W. Parrish as the Chief Executive Officer of the Healthcare Supply Chain Services sector, accompanied by a detailed compensation package including salary, bonus targets, and substantial equity grants. The filing also announces the election of Philip L. Francis to the Board of Directors and his appointment to the Audit Committee, along with details of his compensation as a director. These changes indicate a focus on strengthening leadership within crucial operational segments and ensuring robust corporate governance. Furthermore, the report touches upon administrative amendments to the Management Incentive Plan, notably incorporating provisions for the repayment of bonuses under specific circumstances such as a participant's violation of non-competition covenants or in cases of financial restatements due to misconduct. Changes to directors' equity agreements, including a new one-year holding period, are also disclosed. Overall, these updates suggest proactive measures in executive management, compensation structure, and board oversight.

Key Highlights

  • 1Mark W. Parrish appointed CEO of Healthcare Supply Chain Services sector.
  • 2Parrish's compensation includes $700,000 base salary, 100% target bonus, and significant equity grants (options and RSUs).
  • 3Parrish's employment agreement outlines severance benefits, including salary continuation and accelerated vesting of equity upon termination without cause or constructive dismissal.
  • 4Philip L. Francis elected to the Board of Directors and Audit Committee; receives director compensation including stock options and RSUs with a one-year vesting period.
  • 5Cardinal Health's Management Incentive Plan amended to include provisions for bonus repayment under specific circumstances, such as misconduct leading to financial restatements or violation of non-competition clauses.
  • 6Changes made to directors' stock option and RSU agreements, introducing a one-year holding period for equity awards.

Frequently Asked Questions

The most significant leadership change is the appointment of Mark W. Parrish as the Chief Executive Officer of Cardinal Health's Healthcare Supply Chain Services sector. Additionally, Philip L. Francis was elected to the Board of Directors.

Mr. Parrish will receive an annual base salary of $700,000, with a target annual bonus of 100% of his base salary. He will also receive equity grants, including stock options and restricted stock units (RSUs), with various vesting schedules.

The amendments allow the company to require repayment of bonuses if a participant violates non-competition covenants or if a financial restatement is necessary due to misconduct by the participant that contributed to the restatement. This aims to enhance accountability and align executive compensation with accurate financial reporting.

Yes, the company has updated its directors' stock option and RSU agreements. A key change is the implementation of a one-year holding period requirement for equity grants awarded to non-management directors.